Τόμος 3 (1989) – Τεύχος 1 – Άρθρο 3 – Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Διεθνής Έκδοση – Volume 3 (1989) – Issue 1 – Article 3 – Epitheorese Klinikes Farmakologias και Farmakokinetikes-International Edition

3^rd Department of Internal Medicine, Red Cross Hospital, Athens, Greece

pharmakonpress[at]pharmakonpress[.]gr

2.         Weinberger, M., Hendeles, L., Ahrens, R.: Pharmacological management of reversible obstructive airways disease. Med Clin. North Am. 65: 579 (1980)

3.         Hendeles, L, Weinberger, M.: Theophylline. A “State of the Art”. Review Pharmacotherapy 3: 2 (1983)

4. Lafrate, P.R., Massey, K.C., Hendeles, L.: Current con¬cepts in clinical therapeutics. Asthma Clin. Pharm. 5: 206 (1986)

5.         Hendeles, L., Weinberger, M., Bighley, L: Disposition of theophylline following a single intravenous amrnophylline infusion. Am. J. Hosp. Pharm. 34: 525 (1977)

6.         Jonkman, J.H.G., Tang, D., Upton, R.A., Riegelman, S.: Measurement of excretion characteristics of theophylline and its major metabolites. Eur. J. Clin. Pharmacol. 20: 435 (1981)

7.         Oglivie, R.I.: Clinical pharmacokinetics of theophylline. Clin. Pharmacokinet. 3: 267 (1978)

8.         Simmons, K.S., Simons, F.E.R., Briggs, C.J., Lo, L.: Theophyllin protein binding in humans. J. Pharm. Sci. 68: 252 (1979)

9.. Jenne, J., Nagasawa, H.T., Thompson, R.D.: Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin. Pharmacol. Ther. 19: 375 (1976)

10.       Lohmann, S.M., Miech, R.P.: Theophylline metabolism by the rate liver microsomal system. J. Pharmacol. Exp. Ther. 196: 213 (1976)

11.       Tang-Liu, D.D.-S., William, R.C., Riegelman, S.: Nonlinear theophylline elimination. Clin. Pharmacol. Ther. 31: 35 (1982)

12.       Mitenko, P.A., Dglivie, R.I.: Rational intravenous doses of theophylline. N. Engl. J. Med. 289: 600 (1973)

13.       Hendeles, L., Weinberger, M.r Wratt, R.: Guide to oral theophylline therapy for the treatment of chronic asthma. Am. J. Dis. Child. 132: 876 (1978)

14.       Svedmyr, Κ.: Effects of oral theophylline combined with oral and inhaled b2-adrenostimulants in asthmatics. Allergy 37: 119 (1982)

15.       Weinberg, M., Hendeles, L.: Slow-release theophylline. Rational and basis for product selection. N. Engl. J. Med. 308: 160 (1983)

16.       Billing, B., Dahlqivst, R., Garle, M., Hornblad, Y., Ripe, E.: Separate and combined use of terbutaline and theophylline in asthmatics. Eur. J. Respir. Dis. 63: 399 (1982)

17.       Chodosh, S., Baigelman, W.: The use of theophylline in non-asthmatic chronic obstructive lung disease. Triangle 24: 1 (1985)

18.       Lesko, L.J., Brousseasu., D., Canada, A.T., Eastwood, G.: Temporal variations in through serum theophylline concentrations at steady state. J. Pharm. Sci. 69: 358 (1980)

19.       Riegelman, S., Muir, Κ., Upton, R.: Factors affecting the pharmacokinetics of theophylline. Eur. J. Respir. Dis. 61 (suppl.): 67 (1980)

20.       Jonkman, J.H.G., Upton, R.A.: Pharmacokinetic drug interactions with theophylline. Clin. Pharmacokinet. 9: 309 (1984)

21.       Kadlec, G.L., Thahl Ha, L., Jarboe, C.H. et al.: Effect of ampicillin on theophylline half-life in infants and young children. South Med. J. 71: 1584 (1978)

22.       Pfeifer, H.J., Greenblatt, D.J., Friedman, P.: Effect of three antibiotics on theophylline kinetics. Clin. Pharmacol. Ther. 26: 36 (1979)

23.       Jonkman, J.H.G., van der Boon, W.J.V., Schoenmaker, R. et al.: The influence of cefaclor on the clinical pharmacokinetics of theophylline. Proceedings of the Second European Congress on Biopharmaceutics and Pharmacokinetics, Salamanca, Spain, 1984

24.       Jonkman, J.H.G., van der Boon, W.J.V., Schroenmake, R. et al.: Clinical pharmacokinetics of theophylline during co-treatment with cefaclor. Int. J. Clin. Pharmacol. Ther. Tox. 24: 88 (1986)

25.       Mathis, J.W., Prince, R.A., Weinberger, M.M., Mc Elnay, J.C.: Effect of tetracycline hydrochloride on theophylline kinetics. Clin. Pharm. 1: 446 (1982)

26.       Descotes, J., Ande, Ph., Eyreux, J.C.: Pharmacokinetic drug interactions with macrolide antibiotics. J. Antimicrob. Chemother. 15: 659.(1985)

27.       Pessayre, D., Larrey, D., Funck-Brentano, C., Benhamou, J.P.: Drug interactions and hepatitis produced by some macrolide antibiotics. J. Antimicrob. Chemother. 16 (suppl. A): 181 (1985)

28.       Ludden, Th.M.: Pharmacokinetics interactions of the macrolide antibiotics. Clin. Pharmacokinet. 10: 63 (1985)

29.       Cummings, L.H., Kozak, P.P., Gillman. A.: Erythromycin’s effect on theophylline blood levels. Pediatrics 59: 144 (1977)

30.       Kozak, P.P., Cummings, L.H., Gillman, A.: Administration of erythromycin lactobionate on theophylline clearance. J. Allergy Clin. Immunol. 60: 149 (1977)

31.       Pfeifer, H.J., Greenblatt, D.J., Friedman, P.: Effect of antibiotics on theophylline kinetics in humans. Clin. Pharmacol. Ther. 23: 124 (1978)

32.       Melethil, S., Dutta, A., Ryan, P.B. et al.: Steady state urinary excretion of theophylline and its metabolites in the presence of erythromycin. Res. Commun. Chem. Pathol. Pharmacol. 35: 341 (1982)

33.       Reisz, G.R., Ryan, B.B., Melethil, S., Pingleton, S.K.: Erythromycin induced changes in theophylline kinetics in chronic asthmatics. Am. Rev. Resp. Dis. 125: 95 (1982)

34.       Pingleton, S.K., Kelly, S.J., Ryan, B.B.: Lack of effect of erythromycin on theophyllin serum levels. (Correspondence). Chest 78: 352 (1980)

35.       Kimelblat B.J., Slaughter, R.L., Pingleton, S.K.: Lack of effect of intravenous erythromycin lactobionate on theophylline clearance (correspondence). J. Allergy Clin. Immunol. 65: 313 (1980)

36.       Le Force, C., Miller, M., Chai, H.: Effect of erythromycin on theophylline clearance in asthmatic children. J. Pediatr. 99: 153 (1981)

37.       Prince, R.A., Wing, D.S., Weinberger, M.M. et al.: Effect of erythromycin on theophyllin kinetics. J. Allergy Clin. Immunol. 68: 427 (1981)

38.       May, D.C., Jarbee, C.H., Ellenburg, D.T. et al.: The effect of erythromycin on theophylline elimination in normal males. J. Clin. Pharmacol. 22: 125 (1982)

39.       Renton, R.W., Gray, J.D., Hung, O.R.: Depression of theophylline elimination by erythromycin. Clin. Pharmacol. Ther. 30: ,422 (1981)

40.       Zarowitz, B., Szefler, S.J., Lasezkay, G.M.: Effect of erythromycin base on theophylline kinetics. Clin. Pharmacol. Ther. 26: 36 (1979)

41.       Maddux, M.S., Leeds, N.H., Organek, H.W. et al.: The effect of erythromycin on theophylline pharmacokinetics at steady state. Chest 81: 563 (1982)

42.       Parrish, R.A., Haulman, N.J., Burns, R.M.: Interaction of theophylline with erythromycin base in a patient with seizure activity. Pediatrics 72: 828 (1983)

43.       Hildebrabdt, R., Gundert-Remy, U., Moller, H., Weber, E.: Lack of clinically important interaction between erythromycin and theophylline. Eur. J. Clin. Pharmacol. 26: 485 (1984)

44.       Stults, B.M., Felice-Johnson, J., Higbee, M.D., Hardigan. Κ.: Effect of erythromycin stearate on serum theophylline concentration in patients with chronic obstructive lung disease. South Med. J. 76: 714 (1983)

45.       Green, J.A., Clementi, W.A.: Decrease in theophylline clearance after administration of erythromycin to a patient with obstructive lung disease. Drug Intell. Clin. Pharm. 17: 370 (1983)

46.       Stratton, M.A.: Theophylline-erythromycin base interaction: Case report and kinetic profile. Clin. Pharm. 2: 183 (1983)

47.       Iliopoulos, A., Aldhous, M.E., Johnston, A., Turner, P.: Pharmacokinetic interaction between theophylline and erythromycin. Br. J. Clin. Pharmacol. 14: 495 (1982)

48.       Hemsworth, T.C., Renton, Κ.: Depression of theophylline metabolism and elimination by toleandomycin and erythromycin. Biochem. Pharmacol. 30: 1299 (1981)

49.       Danan, G., Descatoire, V., Pessayre, D.: Self-induction of erythromycin of its own transformation into a metabolite forming an inactive complex with reduced cytochrome P-450. J. Pharmacol. Exp. Ther. 218: 509 (1981)

50.       Weinberger, M., Hudgel, D., Spector, C., Chidsex, C.: Inhibition of theophylline clearance by troleandomycin. J. Allergy Clin. Immunol. 59: 228 (1977)

51.       Brazier, J.L., Kofman, J., Faucon, G. et al.: Retard d’elimination de la theophylline du & la troeleundomycine. Absence d’effet de la josamycine. Therapie 35: 545 (1980)

52.       Lavarene, J., Paire, M., Talon, D.: Influence d’un nouveau macrolide, la midecamycine sur les taux sanguins de theophylline. Th6rapie 36: 451 (1981)

53.       Thompson, J.R., Burckart, G.J., Self, T.H. et al.: Isoniazid-induced alterations in theophylline pharmacokinetics. Curr. Ther. Res. 32: 921 (1982)

54.       Hauser, A.R., Lee, C., Teague, R.B., Mullins, C.: The effect of rifampin on theophylline disposition. Clin. Pharmacol. Ther. 33: 254 (abstract) (1983)

55.       Strughn, A.B., Henderson, R.P., Lieberman, Ph.L, Self, T.H.: Effect of rifampicin on the excretion of theophylline. Ther. Drug Monit. 6: 153 (1984)

56.       Robson, R., Miners, J., Wing, L. et al.: Theophylline-rifampin interaction: nonselective induction of theophylline metabolic pathways. Br. J. Clin. Pharmacol. 18: 445 (1984)

57.       Powell-Jackson, P., Jamieson, A., Gray, B. et al.: Effect of rifampicin administration on theophylline pharmacokinetics in humans. Am. Rev. Resp. Dis. 131: 939 (1985)

57a. Boyce, E.Q., Dukes, G.E., Rollins, D.E.: The effect of rifampin at theophylline disposition. Clin. Pharmacol. Ther. 37: 183 (1985)

58.       Brocks, D.R., Lee, K.C., Weppler, C.P., Tam, Y.K.: Theophylline-rifampin interaction in a pediatric patient. Clin. Pharm. 5: 602 (1986)

59.       Reitberg, D.p., Klarnet, J.P., Carlson, J.K., Schentag, J.J.: Effect of metronidazole on theophylline pharmacokinetics. Clin. Pharm. 2: 441 (1983)

60.       Maesen, F.P.V., Teengs, J.P., Baur, C., Davies, B.I.: Quinolones and raised plasma concentrations of theophylline. Lancet, ii: 530 (1984)

61.       Wijnads, W.J.A., van Herwaarden, C.L.A., Vree, T.B.: Enoxacin raises plasma theophylline concentrations. Lancet ii: 108 (1984)

62.       Gregoire, S.L., Grasela, T.H., Freer, J.P. et al.: Inhibition of theophylline clearance by coodministered ofloxacin without alteration of theophylline effects. Antimicrob. Agents Chemother. 31: 315 (1981)

62a. Raoof, S., Wollschlager, C., Kahn, F.: Serum theophylline levels are increased by ciprofloxacin (Bax 09867), a new quinolone antibiotic (abstr.). Chest 88 (suppl. 1): 325 (1985)

62b. Raoof, S., Wollschlager, C., Kahn, F.: Ciprofloxacin increases serum levels of theophylline. Am. J. Med. 82 (suppl. 4A): 115 (1987)

63.       Murphy, E., Hannon, D., Callaghan, B.: Reduced serum theophylline levels with concominant ketoconazole: First report. Irish Med. J. 80: 123 (1987)

63a. Jakson, J.E., Powell, J.R., Wandell, M. et al.: Cimetidine-theophylline interaction. Pharmacologist 22: 231 (1980)

64.       Jakson, J.E., Powell, J.R., Wandell, M. et al.: Cimetidine decreased theophylline clearance. Am. Rev. Resp. Dis. 123: 615 (1981)

65.       Jakson, J.E., Plachetka, J.R.: More on cimetidine theophylline interaction. Drug Intell. Clin. Pharm. 15: 809 (1981)

66.       Roberts, R.K., Grice, J., Wood, L et al.: Cimetidine impairs the elimination of theophylline and antipyrine. Gastroenterology 81: 19 (1981)

67.       Reitberg. D.P., Bernhard, H., Schentag, J.J.: Alteration of theophylline clearance and half-life by cimetidine in normal volunteers. Ann. Intern. Med. 95: 582 (1981)

68.       Breen, K.J., Bury, R., Desmond, P.V. et a I.: Effects of cimetidine and ranitidine on hepatic drug metabolism. Clin. Pharmacol. Ther. 31: 297 (1982)

69.       Lalonde, R.L., Koob, R.A., McLean, W.M., Balsys, A.J.: The effects of cimetidine on theophylline pharmacokinetics at steady-state. Chest 83: 221 (1983)

70.       De Angel is, C., Walker, S.E., Barrtle, W.: Effect of low dose cimeticine on theophylline clearance. Clin. Pharm. 2: 563 (1983)

71.       Mulkey, P.M., Murphy, J.E., Schleider, N.H.: Steady- state theophylline pharmacokinetics during and after short-term cimetidine administration. .Clin. Pharm. 2: 439 (1983)

72.       Cluxton, R.J., Rivera, J.O., Ritschel, W.A. et al.: Cimetidine-theophylline interaction. Ann. Intern. Med. 96: 684 (1982)

73.       Lofgen, R.P., Gilherston, R.A.: Cimetidine and theophylline. Ann. Inter. Med. 96: 378 (1982)

74.       Miners, J.O., Grygiel, J.J., Drew, R., Birkett, D.J.: Interaction between cimetidine and theophylline in smokers and non-smokers. Clin. Exp. Pharmacol. Physiol. 8: 633 (1981)

75.       Ozzan, D., Uzzan, B., Bernard, N., Canbarrere, I.: Interaction medicamenteuses de la cimetidine et de la theophylline. Nouv. Presse Med. 11: 1950 (1982)

76.       Campbell, M.A., Plachetka, J.R., Jackson, J.E. et al.: Cimetidine decreases theophylline clearance. Ann. Intern. Med. 95: 68 (1981)

77.       Vestal, R.E., Thummel, K.E., Musser, B., Mercer, G.R.: Cimetidine inhibits the theophylline clearance in patients with chronic obstructive pulmonary disease: A study using stable isotope methodology during multiple oral dose administration. Br. J. Clin. Pharmacol. 15: 411 (1983)

78.       Green, A.W., Erling, W., Gardner, M.J., Jusko, W.J.: Cimetidine-methylprednizolone-theophylline metabolic interaction. Am. J. Med. 77: 115 (1984)

79.       Bauman, J.H., Kimelblatt, B.J.: Comment on effect of cimetidine in theophylline clearance. Drug Intell. Ctin. Pharm. 15: 808 (1981)

80.       Hendeles, L., Weinberger, M., Smith, G. et al.: The interaction of cimetidine and theophylline. Drug Intell. Clin. Pharm. 15: 808 (1981)

81.       Jackson, J.E., Plachetka, J R.: More on cimetidine-theophylline interaction. Drug Intel!. Clin. Pharm. 115: 809 (1981)

82.       Ambrose, P.J., Harrals, A.F.: More on cimetidine- theophylline interaction (reply). Drug Intell. Clin. Pharm. 15: 810 (1981)

83.       Sorkin, E.M., Darvey, D.C.: Review of .cimetidine drug interactions. Drug. Intell. Clin. Pharm. 17: 110 (1983)

84.       Reilly, E.B.P., Winzer, J.D.: Adverse drug interaction with cimetidine: competitive inhibition of monoxygenase-dependent N-demethylation of morphine. Biochem. Pharmacol. 33: 1151 (1984)

85.       Berned, B.D., Conner, Ch.S., Sawyer, D.R., Siepler, J.K.: Ranitidine: A new H2-receptor antagonist. Clin. Pharm. 1: 499 (1982)

86.       Ruff, F.: Interferences medicamenteuses de la theophylline. Absence d’interaction theophylline-ranitidine. Nouv. Presse Med. 11: 3512 (1982)

87.       Powell, J.R., Rogers, J.F., Wargin, W.A. et al.: Inhibition of theophylline clearance by cimetidine but not ranitidine. Arch. Intern. Med. 144: 484 (1984)

88.       Fernandes, E., Melewicz, I.M.: Ranitidine and theohylline (Letter). Ann. intern. Med. 100: 459 (1984)

89.       Gardner, M.E., Sikorski, G.W.: Ranitidine and theophylline (letter). Ann. Intern. Med. 102: 559 (1985)

90.       Breen, K.J., Bury, R., Qesmond, P.V. et al.: Effects of cimetidine and ranitidine on hepatic drug metabolism. Clin. Pharmacol. Ther. 31: 297 (1982)

91.       Fauci, A.C., Dale, D.C., Balow, J.E.: Glucocorticoid therapy: mechanisms of action and clinical considerations. Ann. Intern. Med. 84: 304 (1976)

92.       Buchanan, N., Hurwitz, S., Butler, P.: A possible interaction between hydrocortisone and theophylline. South Afr. Med. J. 56: 1147 (1979)

93.       Bunker-Soler, A.L., Leavengood, D.C., Nelson, H.S.: The effect of corticosteroids on theophylline metabolism. Ann. Allergy 41: 133 (1981)

94.       Leavengood, D.C., Bunler-Soler, A.L., Nelson, H.S.: The effect of corticosteroids on theophylline metabolism. Ann. Allergy 50: 249 (1983)

95.       Albin, H., Vincon, G., Bezier, M., Pehourco, F., Cabanien, G.: Pharmacokingtique de la theophylline par voie orale chez des malades asthmatiques sous corticotherapie au long cours. Thirapie 38: 333 (1983)

96.       Arnold, L.A., Spurbeck, L.E., Shelver, W.H. et al.: Effect of antacid on gastrointestinal absorption of theophylline. Am. J. Hosp. Pharm. 36: 1059 (1979)

97.       Shangel, L., Stevenn, J.A., Fuchs, J.E., Yu, A.B.C.: Effect of antacid on the bioavailability of theophylline from rapid and time-released drug products. Abstract. Ann. Pharm. Assoc. Acad Pharm. Set. 10: 89 (1980)

98.       Darzentas, L.J., Stewart, R.B., Curry, S.H., Vost, R.L.: Effect of antacid bioavailability of a substained-released theophylline preparation. Drug Intell. Clin. Pharm. 17: 555 (1983)

99.       Myhre, K.I., Walstad, R.A.: The influence of antacid on the absorption of two different sustained release formulations of theophylline. Br. J. Clin. Pharmacol. 15: 683 (1983)

100.     Jonkan, Biopharmaceutical and pharmacokinetic drug interactions with theophylline. In: The Use of Sustained Release Theophylline in the Treatment of Chronic Reversible Airways Obstruction (J.H.G. Jonkman, ed.), p. 98. Amsterdam, Excerpta Medica, 1984

101.     Lohmann, S.M., Miech, R.P.: Theophylline metabolism by the rat liver microsomal system. J. Pharmacol. Exp. Ther. 196: 213 (1976)

102.     Grygiel, J.J., Wing, L.M.H., Farkas, J., Birket, D.J.: Effects of allopurinol on theophylline metabolism and clearance. Clin. Pharmacol. Ther. 26: 660 (1979)

103.     Vohez, S., Powell, R., Cupit, G.C. et al.: Influence of allopurinol on theophylline disposition in adults. Clin. Pharmacol. Ther. 27: 194 (1980)

104.     Mantredi, R.L., Vessel, E.S.: Inhibition of theophylline metabolism by long-term allopurinol administration. CUn. Pharmacol. Ther. 29: 224 (1981)

105.     McElnay, J.C., Smith, G.D., Helling, D.K.: A practical guide of interactions involving theophylline kinetics. Drug Intell. Clin. Pharm. 16: 533 (1982)

106.     Peruca, E., Hedges, A., Makki, K.A., Richens, A.: A comparative study of antipyrine and lignocaine disposition in normal subjects and in patients treated with enzyme-inducing drugs. Br. J. Clin. Pharmacol. 10: 491 (1980)

107.     Hendeles, L., Wratt, R., Weinberger, M. et al.: Decreased oral phenytoin absorption following concurrent theophylline administration. J. Allergy Clin. Immunol. 63: 156 (Abstract) (1979)

108.     Marquis, J.F., Carruthers, S.G., Spence, J.D. et al.: Phenytoin-theophylline interaction. N. Engl. J. Med. 307: 1189 (1982)

109.     Miller, M.E., Cosgriff, J.M., Morken, D., Kwong, T.: The effect of dilantin on theophylline elimination. Clin. Res. 31: 104A (1983)

110.     Williams, J.F., Szetivanyi, A.: Implications of hepatic drug-metabolizing activity in the therapy of bronchial asthma. J. Allergy Clin. Immunol. 55: 125 (1975)

111.     Panday, R.A., Gonzalez, M.A., Taylor, J.C.: Effect of phenobarbital on theophylline metabolism in asthmatic children. Ann. Allergy 39: 69 (1977)

113.     Grqen, J., Danish, M., Ragni, M. et al.: The effect of phenobarbital upon theophylline elimination kinetics in asthmatic children. Ann. Allergy 39: 69 (1977)

114.     Piafsky, K.M., Sitar, D.S., Ogilvie, R.I.: Effect of phenobarbital on the disposition of intravenous theo¬phylline. Clin. Pharmacol. Ther. 22: 336 (1977)

115.     Paladino. J.A., Blumer, N.A., Maddux, R.R.: Effect of secobarbital on theophylline clearance. Ther. Drug Monit. 5: 135 (1983)

116.     Simons, K.J., Simons, F.E.K.: Urinary excretion of diphylline in humans. J. Pharm. Sci. 68: 1327 (1979)

117.     Rosenberry, K.R., Defuso, C.J., Mansomann, H.C., McGeady, S.J.: Reduced theophylline half-life by carbamazepine therapy. J. Pediatr. 102: 472 (1983)

118.     Jusko, W.J., Gardner, M.J., Mangione, A., Schentag, J.J., Kaip, J.R., Vance, J.W.: Factors affecting tjieophylline clearances: Age, tobacco, marihuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbiturates and ethanol. J. Pharmaceut. Sci. 68: 1358 (1979)

119.     Tornatore, K.M., Kanarkowski, R.r McCarthy, T.L, Gardner, M.J., Yurchak, A.M., Jusko, W.J.: Effect of chronic oral contraceptive steroids on theophylline desposition. Eur. J. Clin. Pharmacol. 23: 129 (1982)

120.     Roberts, R.K., Grice, J„ McGuffie, C., Heilborn, L.: Oral contraceptive steroids impairs the eliminations of theophylline. J. Clin. Lab. Med. 101: 821 (1983)

121.     Gardner, M.J., Tornatore, K.M., Jusko, W.J., Kanarkowski, R.: Effects of tobako smoking and oral contraceptives use on theophylline desposition. Br. J. Clin. Pharmacol• 16: 211 (1983)

122.     Corsenn, G., Gutierrez, J., Reves, J.C., Huber, F.G.: Ketamine in the anesthetic management of asthmatic patients. Anesth. Analg. 51: 588 (1972)

123.     Hirshman, C.A., Krieger, W„ Littlejohn, G.r Lee, R., Julien, R.: Ketamine-aminophylline-induced decreased in seizure threshold. Anesthesiology 56: 464 (1982)

124.     Grambau, G.R., Conlon, R.F., Johnson, C.E., Weg, J.G.: Predicted versus actual plasma theophylline concentrations at steady-state and as influenced by furosemide. Am. Rev. Resp. Dis. 117: 166 (1978)

125.     Conlon, P.F., Grambau, G.R., Johnson, C.E., Weg, J.G.: Effect of intravenous furosemide on serum theophylline concentration. Am. J. Hosp. Pharm. 38: 1345 (1981)

126.     Nagakawa, R.S.: Theophylline-furosemide interaction? (Letter). Am. J. Hosp. Pharm. 39: 242 (1982)

127.     Toback, J.W., Gilman, M.E.: Theophylline-furosemide inactivation? (Letter). Pediatrics 71: 140 (1983)

128.     Mangione, A., Imholf, T.E., Le, R.V. et al.: Pharmacokinetics of theophylline in hepatic disease. Chest 13: 616 (1978)

130.     Hemstreet, M.P., Milos, M.V., Rutland, R.O.: Effect of intravenous isoproterenol on theophylline kinetics. J. Allergy din. Immunol. 69: 360 (1982)

131.     Duriseti, S., Groncy, C.E., Galant, S.P.: The effect of metaproterenol in chronic asthmatic children receiving therapeutic doses of theophylline. J. Allergy Clin. Immunol. 162 (1978)

132.     Shenfield, G.M.: Combination bronchodilator therapy. Drugs 24: 414 (1982)

132a. Svedmyr, Κ.: p2-adrenoceptor stimulant and theophylline in asthma therapy. Eur. J. Resp. Dis. 116 (suppl.): 16 (1981)

133.     E. Usdin, P. Skolnick, J.F. Tallman et al. (eds): Pharmacology of Benzodiazepines. Mac Millan, London, 1982

134.     Jusko, W.J., Gardner, M.J., Mangione, A. et al.: Factors affecting theophylline clearances: Age, tobacco, marihuana, cirrhosis, congestive heart failure, obesity, oral contraceptives, benzodiazepines, barbitures and ethanol. J. Pharm. Sci. 68: 1358 {1979)

135.     Abernethy, D.R., Greenblatt, D.J., Ochs, H.R., Shader, R.I.: Benzodiazepines drug-drug interactions commonly occuring in clinical practice. Curr. Med. Res. Opin. 8 (Suppl; 4): 80 (1984)

136.     Tanowitz, H.B., Weiss, L.M., Witner, M.: Diagnosis and treatment of protozoan diarrheas. Am. J. Gastroenter. 83: 339 (1988)

137.     Sugar, A.N.: Thiabendazole. Texas Rep. Biol. Med. 27: 533 (1969)

138.     Baldessarini, R.J.: Chemotherapy in psychiatry. Cambridge, Massachusetts, Harvard University Press, 1977

139.     Thompson, K., Schon, M.: Renal lithium excretion in man. Am. J. Physiol. 215: 823 (1968)

140.     Gok, B.L.: Theophyllrne-lithium interaction. J. din. Psychiatry 46: 278 (1985)

141.     Sierles, F.S., Ossowski, M.G.: Concurrent use of theophylline and lithium in a patient with chronic obstructive lung disease and dipolar disorder. Am. J. Psychiatry 139: 117 (1982)

142.     Frrshman, W., Silverman, R„ Strom, J. et al.: Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker. Am. Heart J. 98: 256 (1979)

143.     Kendall, M.J., Beeley, L.: Beta-adrenoceptor blocking drugs: Adverse reactions and drug interactions. Pharmacol Ther. 21: 351 (1983)

144.     Wood, A.J.J., Feely, J.: Pharmacokinetic drug interactions with propranolol. Clin. Pharmacokinet. 8: 253 (1983)

145.     Conrad, K.A., Nyman, D.W.: Effects of metoprolol and propranolol on theophylline elimination. Clin. Pharmacol. Ther. 28: 463 {1980)

146.     Miners, J.O.: Selectivity and dose-dependency of the inhibitory effect of propranolol on theophylline metabolism in man. Br. J. Clin. Pharmacol. 20: 219 {1985)

147.     Albidi, R., McCallum, R.W.: Metoclopramide: pharmacology and clinical application. Ann. Intern. Med. 98: 86 (1983)

148.     Steeves, R.A., Robinson, J.D., McKenzie, M.W., Justus, P.G.: Effects of metoclopramide on the pharmacokinetics of a slow release theophylline product, Clin. Pharm. 1: 356 (1982)

148a. Plessas, C.T., Plessas, S.T.: Antiplatelet drugs. Clinical pharmacology and pharmacokinetics. Epitheor. Clin. Farmacot. Farmacokinet. (Int. Ed.) 1: 5 (1987)

149.     Colli, A., Buccino, G., Cocciolo, M., Parravicini, R., Elli, G.M., Saltrini, G.: Ticlopidine-theophylline interaction. Clin. Pharmacol. Ther. 41: 358 (1987)

149a. Plessas, C.T., Plessas, S.T.: Biological effects of caffeine. Epitheor. Clin. Farmacot. Farmacokinet. 3: 7 (1985)

150.     Monsk, T.J., Lawrice, C.A., Caldwell, J.: The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man. Drug Dispos. 2: 31 (1981)

151.     May, D.C., Jarboe, C.H.: Inhibition of clearance on diphylline by probenecid. N. Engl. J. Med. 304: 791 (1981)

152.     May, D.C., Jarboe, C.H.: Effect of probenecid on diphylline elimination. Clin. Pharmacol. Ther. 33: 822 (1983)

153.     Chen, T.W.D., Patto, T.F.: Effect of probenecid on the pharmacocinetics of aminophylline. Drug Intell. Clin. Pharm. 17: 465 (1983)

154.     Birket, D.J., Miners, J.O., Attwood, J.: Evidence for a dual action of sulphinpyrazone on a drug metabolism in man. Br. J. Clin. Pharmacol. 15: 567 (1983)

155.     Gannon, R„ Sullman, S., Levy, R.M., Grober, J.: Possible interaction between vidarabine and theophylline. Ann. Intern. Med. 101: 148 (1984)

156.     Zsoter, T.T., Church, J.G.: Calcium antagonists: Pharmacodynamic effects and mechanism of action. Drugs 25: 93 (1983)

157.     Bournakis, T.G., Seldon, M., Czapliki, A.D.: Increased serum theophylline concentration secondary to oral verapamil. Clin. Pharm. 2: 458 (1983)

158.     Parrillo, S.I., Venditto, M.: Elevated theophylline blood levels from institution of nifedipine therapy. Ann. Emerg. Med. 13: 316 (1984)

159.     Jackson, S.H.D.: The interaction between i.v. theophylline and chronic oral dosing with slow release nifedipine in volunteers. Br. J. Clin. Pharmacol. 21: 389 (1986)

160.     Garty, M.: Effect on nifedipine and theophylline in asthma. Clin. Pharmacol. Ther. 40: 195 (1986)

161.     Harrod, C.S.: Theophylline toxicity and nifedipine. Ann. Intern. Med. 106: 480 (1987)

162.     Chang, K.C., Bell, T.D., Lauer, B.A., Chai, H.: Altered theophylline pharmacokinetic during acute respiratory viral illness. Lancet 1: 1132 (1978)

163.     Renton, K.W., Gray, J.D., Hall, R.I.: Decreased elimination of theophylline after influenza vaccination. Can. Med. Ass. J. 123: 288 (1980)

164.     Walker, S., Schreiber, L., Middelkamp, J.N.: Serum theophylline levels after influenza vaccination. Can. Med. Ass. J. 124: 243 (1981)

165.     Kraemer, M.J., Furukawa, C.T., Koup, J.R. et al.: Altered theophylline clearance during an influenza B outbreak. Pediatrics 69: 476 (1982)

166.     Goldstein, R.S., Cheung, O.T., Seguin, R. et al.: Decreased elimination of theophylline after influenza vaccination. Can. Med. Ass. J. 126: 470 (1982)

167.     Fischer, R.G., Booth, B.H., Mitchell, D.Q., Kibbe, A.H.: Influence of trivalent influenza vaccine on serum theophylline levels. Can. Med. Ass. J. 126: 1312 (1982)

168.     Britton, L., Ruben, F.L.: Serum theophylline levels after influenza vaccination. Can. Med. Ass. J. 126: 1375 (1982)

169.     San Joaquin, V.H., Reyes, S., Marks, M.I.: Influenza vaccination on asthmatic children on maintenance theophylline tehrapy. Clin. Pediatr. 21: 724 (1982)

170.     Stults, B.M., Hashisaki, P.A.: Influenza vaccinations and theophylline pharmacokinetics in patients with chronic obstructive lung disease. West J. Med. 139: 651 (1983)

171.     Patriarca, P.A., Kendal, A.P., Stricol, R.L. et al.: Influenza vaccination and warfarin on theophylline toxicity in nursing home residents. N. Engl. J. Med. 308: 1601 (1983)

172.     Hunt, S.N., Jusko, W.J., Hurchak, A.M.: Effect of smoking on theophylline disposition. Clin. Pharmacol. Ther. 19: 546 (1976)

173.     Powell, J.R., Thiercelin, J.F., Voseh, S., Sandon, L., Riegelman, S.: The influence of cigarette smoking and sex on theophylline disposition. Am. Rev. Resp. Dis. 166: 12 0977)

174.     Pheifer, H.F., Greenblat, D.J.: Clinical toxicity of theophylline in relation to cigarette smoking. Chest 73: 455 (1978)

175.     Jusko, W.J., Schental, J.J., Clark, J.H., Gardner, M., Hurchak, A.M.: Enhanced biotransformation of theophylline in marihuana and tobacco smokers. CUn. Pharmacol. Ther. 24: 406 (1978)

176.     Jusko, W.J.: Influence of cigarette smoking on drug metabolism in man. Drug Metab. Rev. 9: 221 (1979)

177.     Grygiel, J.J., Birkett, D.J.: Cigarette smoking and theophylline clearance and metabolism. Clin. Pharmacol. Ther. 30: 491 (1981)

178.     Cusack, B.J., Dawson, G.W., Mercer, G.D., Vestal, R.G.: Cigarette smoking and theophylline metabolism: Effect of cimetidine. Clin. Pharmacol. Ther. 37: 330 (1985)

179.     Lee, B.L., Benowitz, N.C., Jacob, P.: Cigarette abstinence, nicotine gum and theophylline disposition. Ann. intern. Med. 106: 553 (1987)

180.     Dawson, G.W., Vestal, R.E.: Smoking and drug metabolism. Pharmacol. Ther. 15: 207 (1982)

181.     Jusko, W.J.: Role of tobacco smoking in pharmacokinetics. J. Pharmacokinet. Btopharm. 6: 7 (1978)

182.     Kappas, A., Anderson, K.E., Conney, A.H., Alvares, A.P.: Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man. Clin. Pharmacol. Ther. 20: 643 (1976)

183.     Feldman, C.H., Hutchinson, V.E., Pippenger, C.E., Blumenfeld, T.A., Feldman, B.R., Davis, W.3.: Effect of dietary protein and carbohydrate on theophylline metabolism in children. Pediatrics 66: 956 (1980)

pharmakonpress[at]pharmakonpress[.]gr

pharmakonpress[at]pharmakonpress[.]gr